These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38576025)

  • 21. Aging Brain, Dementia and Impaired Glymphatic Pathway: Causal Relationships.
    Shirolapov I; Zakharov A; Smirnova D; Khivintseva E; Sergeeva M
    Psychiatr Danub; 2023 Oct; 35(Suppl 2):236-244. PubMed ID: 37800234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions.
    Yue Y; Zhang X; Lv W; Lai HY; Shen T
    Neural Regen Res; 2024 Sep; 19(9):1973-1980. PubMed ID: 38227524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption.
    Zhang R; Liu Y; Chen Y; Li Q; Marshall C; Wu T; Hu G; Xiao M
    CNS Neurosci Ther; 2020 Feb; 26(2):228-239. PubMed ID: 31364823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring neurodegenerative disorders using advanced magnetic resonance imaging of the glymphatic system.
    Prasuhn J; Xu J; Hua J; van Zijl P; Knutsson L
    Front Psychiatry; 2024; 15():1368489. PubMed ID: 38651012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term High-Fat Diet Impairs AQP4-Mediated Glymphatic Clearance of Amyloid Beta.
    Peng W; Yuan Y; Lei J; Zhao Y; Li Y; Qu Q; Wang J
    Mol Neurobiol; 2024 Jul; ():. PubMed ID: 38958889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    Ota M; Sato N; Nakaya M; Shigemoto Y; Kimura Y; Chiba E; Yokoi Y; Tsukamoto T; Matsuda H
    J Alzheimers Dis; 2022; 90(1):295-303. PubMed ID: 36120782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astroglial water channel aquaporin 4-mediated glymphatic clearance function: A determined factor for time-sensitive treatment of aerobic exercise in patients with Alzheimer's disease.
    Yin M; Pu T; Wang L; Marshall C; Wu T; Xiao M
    Med Hypotheses; 2018 Oct; 119():18-21. PubMed ID: 30122483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage.
    Cao X; Xu H; Feng W; Su D; Xiao M
    Brain Res Bull; 2018 Oct; 143():83-96. PubMed ID: 30347264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease.
    Si X; Dai S; Fang Y; Tang J; Wang Z; Li Y; Song Z; Chen Y; Liu Y; Zhao G; Zhang B; Pu J
    J Adv Res; 2024 Feb; 56():125-136. PubMed ID: 36940850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice.
    Simon M; Wang MX; Ismail O; Braun M; Schindler AG; Reemmer J; Wang Z; Haveliwala MA; O'Boyle RP; Han WY; Roese N; Grafe M; Woltjer R; Boison D; Iliff JJ
    Alzheimers Res Ther; 2022 Apr; 14(1):59. PubMed ID: 35473943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Annadurai N; De Sanctis JB; Hajdúch M; Das V
    Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies.
    Formolo DA; Yu J; Lin K; Tsang HWH; Ou H; Kranz GS; Yau SY
    Mol Neurodegener; 2023 Apr; 18(1):26. PubMed ID: 37081555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
    Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photobiomodulation Therapy and the Glymphatic System: Promising Applications for Augmenting the Brain Lymphatic Drainage System.
    Salehpour F; Khademi M; Bragin DE; DiDuro JO
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds.
    Castillo-Carranza DL; Gerson JE; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Kayed R
    J Alzheimers Dis; 2014; 40 Suppl 1():S97-S111. PubMed ID: 24603946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury.
    Iliff JJ; Chen MJ; Plog BA; Zeppenfeld DM; Soltero M; Yang L; Singh I; Deane R; Nedergaard M
    J Neurosci; 2014 Dec; 34(49):16180-93. PubMed ID: 25471560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
    Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
    J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of depression as a risk factor in the development of Alzheimer's disease: the function of AQP4 and the glymphatic system.
    Xia M; Yang L; Sun G; Qi S; Li B
    Psychopharmacology (Berl); 2017 Feb; 234(3):365-379. PubMed ID: 27837334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration.
    Szlufik S; Kopeć K; Szleszkowski S; Koziorowski D
    Cells; 2024 Feb; 13(3):. PubMed ID: 38334678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired brain glymphatic flow in experimental hepatic encephalopathy.
    Hadjihambi A; Harrison IF; Costas-Rodríguez M; Vanhaecke F; Arias N; Gallego-Durán R; Mastitskaya S; Hosford PS; Olde Damink SWM; Davies N; Habtesion A; Lythgoe MF; Gourine AV; Jalan R
    J Hepatol; 2019 Jan; 70(1):40-49. PubMed ID: 30201461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.